NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 1,072 filers reported holding NOVARTIS A G in Q3 2021. The put-call ratio across all filers is 0.22 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $265 | +9.5% | 2,630 | 0.0% | 0.04% | +5.3% |
| Q1 2023 | $242 | -4.0% | 2,630 | -5.4% | 0.04% | -7.3% |
| Q4 2022 | $252 | -99.9% | 2,780 | +5.8% | 0.04% | +24.2% |
| Q1 2022 | $231,000 | -99.1% | 2,627 | -99.1% | 0.03% | -99.0% |
| Q4 2021 | $24,385,000 | +11.4% | 278,786 | +4.1% | 3.32% | +3.1% |
| Q3 2021 | $21,899,000 | -3.5% | 267,779 | +7.7% | 3.22% | -2.4% |
| Q2 2021 | $22,692,000 | +8.0% | 248,702 | +1.2% | 3.30% | +2.4% |
| Q1 2021 | $21,016,000 | -2.4% | 245,856 | +7.8% | 3.22% | -7.0% |
| Q4 2020 | $21,527,000 | +10.5% | 227,971 | +1.7% | 3.46% | -0.5% |
| Q3 2020 | $19,487,000 | +9.3% | 224,087 | +9.8% | 3.48% | +1.4% |
| Q2 2020 | $17,827,000 | +7.8% | 204,105 | +1.8% | 3.43% | -10.6% |
| Q1 2020 | $16,538,000 | -13.9% | 200,585 | -1.2% | 3.84% | +12.1% |
| Q4 2019 | $19,218,000 | +11.6% | 202,954 | +2.4% | 3.42% | +4.6% |
| Q3 2019 | $17,221,000 | -5.3% | 198,174 | -0.5% | 3.27% | -7.2% |
| Q2 2019 | $18,191,000 | -12.1% | 199,224 | -7.5% | 3.53% | -15.2% |
| Q1 2019 | $20,701,000 | +11.3% | 215,321 | -0.7% | 4.16% | +0.4% |
| Q4 2018 | $18,601,000 | -8.3% | 216,772 | -7.9% | 4.14% | +3.6% |
| Q3 2018 | $20,281,000 | +11.3% | 235,390 | -2.4% | 4.00% | +6.3% |
| Q2 2018 | $18,227,000 | +3.0% | 241,283 | +10.3% | 3.76% | -1.8% |
| Q1 2018 | $17,694,000 | -4.1% | 218,844 | -0.4% | 3.83% | -1.6% |
| Q4 2017 | $18,451,000 | -2.2% | 219,757 | -0.0% | 3.89% | -3.2% |
| Q3 2017 | $18,866,000 | +1.0% | 219,758 | -1.8% | 4.02% | -0.8% |
| Q2 2017 | $18,675,000 | +6.8% | 223,738 | -4.9% | 4.05% | +4.7% |
| Q1 2017 | $17,479,000 | +0.6% | 235,347 | -1.3% | 3.87% | -4.3% |
| Q4 2016 | $17,375,000 | +5.4% | 238,542 | +14.2% | 4.04% | +7.5% |
| Q3 2016 | $16,488,000 | -4.3% | 208,815 | -0.0% | 3.76% | -4.7% |
| Q2 2016 | $17,233,000 | +15.1% | 208,864 | +1.0% | 3.94% | +11.4% |
| Q1 2016 | $14,978,000 | -4.8% | 206,768 | +13.0% | 3.54% | -5.7% |
| Q4 2015 | $15,740,000 | +39.9% | 182,942 | +49.5% | 3.76% | +33.0% |
| Q3 2015 | $11,251,000 | -31.9% | 122,402 | -27.1% | 2.82% | -28.6% |
| Q2 2015 | $16,511,000 | -0.9% | 167,900 | -0.6% | 3.96% | -1.1% |
| Q1 2015 | $16,662,000 | +33.1% | 168,973 | +25.1% | 4.00% | +37.2% |
| Q4 2014 | $12,518,000 | -1.7% | 135,101 | -0.2% | 2.92% | -5.3% |
| Q3 2014 | $12,737,000 | +3.5% | 135,309 | -0.4% | 3.08% | +3.1% |
| Q2 2014 | $12,301,000 | -24.7% | 135,876 | -29.3% | 2.99% | -26.7% |
| Q1 2014 | $16,337,000 | +1.6% | 192,150 | -3.9% | 4.08% | -2.5% |
| Q4 2013 | $16,078,000 | +4.1% | 200,030 | -0.7% | 4.18% | -4.1% |
| Q3 2013 | $15,446,000 | +9.1% | 201,358 | +0.6% | 4.36% | +3.0% |
| Q2 2013 | $14,159,000 | – | 200,246 | – | 4.23% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Martin Investment Management, LLC | 229,184 | $23,344,682 | 7.00% |
| Foresight Global Investors, Inc. | 97,500 | $9,397,737 | 5.23% |
| SCHARF INVESTMENTS, LLC | 1,425,745 | $145,226,322 | 4.34% |
| MANAGED ASSET PORTFOLIOS, LLC | 274,204 | $27,930,369 | 4.28% |
| GARLAND CAPITAL MANAGEMENT INC | 54,710 | $5,572,761 | 3.93% |
| PRENTISS SMITH & CO INC | 52,032 | $5,299,980 | 3.91% |
| WILKINS INVESTMENT COUNSEL INC | 130,950 | $13,339 | 3.61% |
| First Fiduciary Investment Counsel, Inc. | 145,731 | $14,844 | 3.48% |
| Cullen Capital Management, LLC | 2,714,809 | $276,530,464 | 3.23% |
| JOHN G ULLMAN & ASSOCIATES INC | 182,690 | $18,608,803 | 3.04% |